当前位置:首页 - 行情中心 - 海翔药业(002099) - 财务分析 - 现金流量表

海翔药业

(002099)

  

流通市值:98.54亿  总市值:98.74亿
流通股本:16.15亿   总股本:16.19亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金348,382,709.371,307,638,032.44993,992,352.52699,368,481.78
  收到的税费返还23,627,173.94112,760,632.65100,327,020.6656,936,665.75
  收到其他与经营活动有关的现金38,130,111.93169,769,566.36133,469,750.34107,995,448.16
  经营活动现金流入小计410,139,995.241,590,168,231.451,227,789,123.52864,300,595.69
  购买商品、接受劳务支付的现金265,801,663.621,016,927,065.45754,301,089.48542,898,159.92
  支付给职工以及为职工支付的现金100,717,738.13341,911,428.04253,652,609.17174,682,411.45
  支付的各项税费30,038,410.4677,788,458.2882,641,878.0262,035,708.15
  支付其他与经营活动有关的现金66,547,691.31213,219,648.23120,235,960.9683,422,200.37
  经营活动现金流出小计463,105,503.521,649,846,6001,210,831,537.63863,038,479.89
  经营活动产生的现金流量净额-52,965,508.28-59,678,368.5516,957,585.891,262,115.8
二、投资活动产生的现金流量:
  收回投资收到的现金-37,956,771.13130,489.88130,489.88
  取得投资收益收到的现金10,211,171.548,842,850.517,272,551.357,272,551.35
  处置固定资产、无形资产和其他长期资产收回的现金净额12,287.69,248,067.72117,441.330,975.8
  收到的其他与投资活动有关的现金1,478,586.32408,738,837.93419,327,624.71404,296,712.03
  投资活动现金流入小计11,702,045.46464,786,527.29426,848,107.24411,730,729.06
  购建固定资产、无形资产和其他长期资产支付的现金25,679,025.2874,460,780.8661,784,910.2845,269,659.38
  投资支付的现金-51,238,562--
  支付其他与投资活动有关的现金120,625,795.9531,459,127.99311,375,983.19309,402,602.66
  投资活动现金流出小计146,304,821.23157,158,470.85373,160,893.47354,672,262.04
  投资活动产生的现金流量净额-134,602,775.77307,628,056.4453,687,213.7757,058,467.02
三、筹资活动产生的现金流量:
  取得借款收到的现金230,000,0002,452,690,0001,777,230,0001,304,700,000
  收到其他与筹资活动有关的现金33,706,000247,140,000205,440,000156,800,000
  筹资活动现金流入小计263,706,0002,699,830,0001,982,670,0001,461,500,000
  偿还债务支付的现金442,530,0002,391,200,0001,771,200,000971,500,000
  分配股利、利润或偿付利息支付的现金6,239,854.7226,292,992.8518,755,203.6913,302,918.04
  支付其他与筹资活动有关的现金125,288,739.6179,313,371.73147,305,569.4287,467,585.96
  筹资活动现金流出小计574,058,594.322,596,806,364.581,937,260,773.111,072,270,504
  筹资活动产生的现金流量净额-310,352,594.32103,023,635.4245,409,226.89389,229,496
四、汇率变动对现金及现金等价物的影响-17,351,551.77-29,127,288.64-5,527,511.73,156,614.34
五、现金及现金等价物净增加额-515,272,430.14321,846,034.67110,526,514.85450,706,693.16
  加:期初现金及现金等价物余额1,257,974,352.09936,128,317.42936,128,317.42936,128,317.42
  期末现金及现金等价物余额742,701,921.951,257,974,352.091,046,654,832.271,386,835,010.58
补充资料:
  净利润--93,754,370.28-12,623,205.93
  资产减值准备-105,382,349.41-22,703,538.03
  固定资产和投资性房地产折旧-316,492,335.73-159,167,374.6
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-316,492,335.73-159,167,374.6
  无形资产摊销-19,705,794.29-10,004,511.65
  长期待摊费用摊销-1,577,469.04-782,127.92
  处置固定资产、无形资产和其他长期资产的损失--31,936.39-26,079.94
  固定资产报废损失--1,572,736.63-175,353.96
  公允价值变动损失-14,790,765.56--6,903,972.57
  财务费用-53,376,284.79-12,732,441.04
  投资损失--55,820,826.72-3,170,767.32
  递延所得税-3,577,921.96-3,490,759.57
  其中:递延所得税资产减少--397,968.49-1,176,532.31
    递延所得税负债增加-3,975,890.45-2,314,227.26
  存货的减少--186,963,223.17--111,184,165.2
  经营性应收项目的减少--163,714,681.23-25,443,647.95
  经营性应付项目的增加--77,676,548.92--133,458,296.19
  现金的期末余额-1,257,974,352.09-1,386,835,010.58
  减:现金的期初余额-936,128,317.42-936,128,317.42
  现金及现金等价物的净增加额-321,846,034.67-450,706,693.16
公告日期2026-04-292026-04-292025-10-292025-08-30
审计意见(境内)标准无保留意见
TOP↑